How Do U.S. Medical Oncologists Learn and Apply New Clinical Trials Information from Press Releases in Nonmedical Media? A Case Study Based on ECOG 4599

Learning Objectives After completing this course, the reader will be able to: Discuss new vehicles for the initial release of practice‐relevant phase III clinical trial data. Describe the limited educational impact of such information transfer vehicles on the medical oncology community. Explain the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The oncologist (Dayton, Ohio) Ohio), 2006-01, Vol.11 (1), p.31-38
Hauptverfasser:	Dornbusch, Daniel, Allegra, Carmen, Willey, Joanne, Andrews, Michele, Leff, Richard, Epstein, James, Jones, James, Lokey, Lee, Green, Mark R.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Antineoplastic Agents - therapeutic use Bevacizumab Carcinoma, Non-Small-Cell Lung - drug therapy Chemotherapy Clinical Trials, Phase III as Topic Diffusion of Innovation Humans Lung cancer Lung Neoplasms - drug therapy Medical education Medical Oncology Organizational Case Studies Practice Patterns, Physicians Societies, Medical Targeted therapy United States
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!